Genelux (GNLX) Return on Capital Employed (2023 - 2026)
Genelux (GNLX) recorded quarterly Return on Capital Employed of 187.59% in Q1 2026, up 10.86% quarter-over-quarter from 210.45% in Q4 2025.
Genelux (GNLX) Return on Capital Employed (2023 - 2026) Analysis & Trends
Genelux's Return on Capital Employed history runs 4 years deep, the most recent figure standing at 187.59% for Q1 2026.
- In Q1 2026, Return on Capital Employed changed N/A year-over-year to 187.59%; the TTM figure through Mar 2026 stood at 187.59% (changed N/A YoY), while the FY2025 annual figure was 160.87%, down 3098.0% from the prior year.
- Return on Capital Employed was 187.59% for Q1 2026 at Genelux, up from 210.45% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 77.88% in Q3 2024 to a low of 210.45% in Q4 2025.
- Historically, Return on Capital Employed has averaged 131.85% across 4 years, with a median of 121.66% in 2024.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 469 bps in 2024, then plunged 10684 bps in 2025.
- A 4-year view of Return on Capital Employed shows it stood at 98.92% in 2023, then decreased by 5 bps to 103.62% in 2024, then slumped by 103 bps to 210.45% in 2025, then gained by 11 bps to 187.59% in 2026.
- The last three Return on Capital Employed figures came in at 187.59% (Q1 2026), 210.45% (Q4 2025), and 142.82% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -187.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -187.59% |
| Dec 31, 2025 | -210.45% |
| Sep 30, 2025 | -142.82% |
| Dec 31, 2024 | -103.62% |
| Sep 30, 2024 | -77.88% |
| Jun 30, 2024 | -93.79% |
| Mar 31, 2024 | -139.71% |
| Dec 31, 2023 | -98.92% |